查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1633752

美國透析中心市場：市場規模、佔有率、趨勢分析（按方式、透析方法、設施和地區）、細分市場預測（2025-2030 年）

U.S. Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-center, In-home, SNF-based), By Dialysis (Hemodialysis, Peritoneal Dialysis, Dialysis Chains), By Facility, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國透析中心市場的成長與趨勢：

根據Grand View Research的新報告，到2030年美國透析中心市場規模預計將達到403.9億美元。

預計 2025 年至 2030 年期間市場複合年成長率為 5.4%。末期腎功能衰竭(ESRD) 的高盛行率和優惠的報銷政策是預計推動成長的一些關鍵因素。由於ESRD盛行率不斷上升，治療費用也逐漸上升。

醫療保險可以報銷腎衰竭治療費用，增加了治療的可近性。醫療保險和醫療補助服務中心宣布了一種新的末期腎病治療選擇模型，以維護和改善慢性腎臟病病患者的報銷。這種新模式鼓勵採用住院治療。 2022 年 8 月，CMS 擴大了腎功能損害治療的報銷資格。擴建也包括某些資本資產，例如主要用於家庭治療的設備。這增加了服務的可訪問性。

由於患者每周大約有三天需要往返中心，因此距離患者居住近通常是選擇中心的重要標準。因此，推出新工廠是領先公司增加市場佔有率的關鍵策略舉措。例如，美國公司 RenalCare 於 2021 年 5 月開設了三家新工廠。這擴大了該公司在西南佛羅裡達州的影響力。

新冠肺炎疫情導致末期腎病患者難以獲得治療，需要他們在一個月內接受多次治療。根據美國國家腎臟基金會的數據，接受末期腎病治療的患者中有 15.8% 感染了 COVID-19。聯邦政府和服務提供者提倡住院治療。 2021 年 6 月，九家領先的醫療保健組織發起了一項新的創新腎臟護理宣傳活動，為患者提供在家接受治療的選擇。

美國透析中心市場：概述

  • 按服務分類，中心部門在 2024 年佔據了最大的收入佔有率。這是因為透析中心需要更順暢的透析協助和照護。此外，對血液透析機的高度偏好也推動了市場機會，因為血液透析機本質上需要去中心並得到幫助。
  • 根據透析方法的類型，血液透析機在 2024 年佔據市場主導地位。這是由於醫療專業人員對血液透析機的偏好以及患者預期壽命的增加。然而，由於腹膜透析能有效清除毒性物質，且患者可在家中獨立接受治療，因此預計預測期內將以最快的速度成長。
  • 根據設施類型，透析連鎖店在 2024 年佔據了市場主導地位。這是因為美國各地都有這樣的透析連鎖店。與醫院設施相比，以較低的成本提供高品質的設備和治療是推動這一領域成長的原因。此外，主要企業正在收購獨立設施，導致大多數獨立設施由連鎖店經營。
  • 自 COVID-19 疫情爆發以來，服務提供者和患者一直面臨挑戰，其中一些挑戰與其他醫療機構和治療團體相比是獨一無二的。例如，血液透析機(HD) 患者每週至少訪問中心三次，並且在每次治療期間，他們會接觸到在特定治療期間同時接受治療的所有患者，並且還會接觸到在往返中心的途中額外接觸的醫護人員。
  • 併購與合作受到大型公司的青睞，因為它們可以透過增加服務價值來獲得競爭優勢。例如，2022年3月，費森尤斯醫療宣布與Interwell Health和Cricket Health合併，以推進更好的腎臟疾病解決方案。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章美國透析中心市場：促進因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL 分析

第 4 章美國透析中心市場：按模式進行的業務分析

  • 按模式分類的市場佔有率（2024 年和 2030 年）
  • 特定於模式的儀表板
  • 按模式分類的市場規模預測和趨勢分析（2018-2030 年）
  • 中心內部
  • 在家裡
  • 基於SNF

第 5 章美國透析中心市場：按透析方法進行的業務分析

  • 按透析方法分類的市場佔有率（2024 年和 2030 年）
  • 按透析方法分類的儀表板
  • 透析法市場規模預測及趨勢分析（2018-2030年）
  • 血液透析機
  • 腹膜透析

第6章美國透析中心市場：按設施分類的業務分析

  • 各設施市場佔有率（2024 年及 2030 年）
  • 設施儀表板
  • 按設施分類的市場規模預測和趨勢分析（2018 至 2030 年）
  • 透析鏈
  • 獨立設施
  • 醫院為基礎

第 7 章：美國透析中心市場：按地區分類的估計和趨勢分析

  • 各地區市場佔有率（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 各地區市場規模預測及趨勢分析（2018-2030年）
  • 西方
  • 中西部
  • 東北
  • 東南
  • 西南

第8章 競爭格局

  • 參與企業概況
  • 公司市場地位分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Fresenius Medical Care AG
    • US Renal Care, Inc.
    • DaVita Inc.
    • Innovative Renal Care
    • DCI
    • SATELLITE HEALTHCARE
    • Northwest Kidney Centers
    • Centers for Dialysis Care
    • Rogosin Institute
    • Dialysis Care Center
    • USCF Health（The Regents of The University of California）
    • Rhode Island Hospital, Department of Health Rhode Island
    • University of Iowa Hospital &Clinics
    • Saint Anthony Hospital
    • Rush University Children's Hospital
Product Code: GVR-4-68039-990-8

U.S. Dialysis Centers Market Growth & Trends:

The U.S. dialysis centers market size is expected to reach USD 40.39 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.4% from 2025 to 2030. The high prevalence of End-Stage Renal Disease (ESRD) and favorable reimbursement are some of the key factors expected to boost growth. The expenditure on treatment is gradually rising due to the increasing prevalence of ESRD.

The availability of Medicare reimbursement for kidney disorder treatment is increasing the accessibility to the treatment. The Center for Medicare & Medicaid Services announced a new end-stage renal diseases treatment choice model for the maintenance & improvement in the reimbursement for chronic kidney disorder patients. The new model is encouraging the use of home-based treatment. In August 2022, the CMS expanded the eligibility for reimbursement for kidney disorder treatment. The expansion includes certain capital assets, mainly equipment used at home for treatment. This is increasing the accessibility to the services.

The patients need to travel to and fro the center for around 3 days per week, the proximity from the patient's residence is generally an important criterion for the center of choice. Hence the launch of new facilities is a key strategic initiative undertaken by major players to increase their market share. For instance, in May 2021, U.S. Renal Care, Inc. inaugurated three new facilities, one in-center facility and two focusing on home therapies. This expanded the company's presence in the Southwest Florida region.

The COVID-19 pandemic resulted in patients facing difficulty in having an access to treatment for end-stage renal disorder, requiring multiple sessions within a month. According to the national kidney foundation, 15.8% of the patients undergoing treatment for end-stage renal disease had COVID-19 infection. The federal government & service providers promoted home treatment. In June 2021, a new campaign innovative kidney care was launched by nine leading healthcare organizations for patient options for receiving home treatment.

U.S. Dialysis Centers Market Report Highlights:

  • Based on service, the in-center segment held the largest revenue share in 2024. This can be attributed to the need for assistance & care for the procedure, which can be facilitated better at the centers. The high preference for hemodialysis is also driving the market opportunity as it essentially requires center visits & assistance.
  • Based on dialysis type, hemodialysis dominated the market in 2024. This can be attributed to the preference for the segment by healthcare professionals & longer life expectancy for patients. However peritoneal dialysis is expected to have the fastest growth during the forecast period owing to the effective removal of toxic substances & high convenience of peritoneal dialysis enabling patients to independently have treatment at home.
  • Based on facility type, dialysis chains dominated the market in 2024. This can be attributed to the presence of such chains throughout the U.S. The availability of top-quality equipment and treatment at a lower cost compared to hospital-based facilities is driving the segment's growth. In addition, the key players are acquiring independent facilities, resulting in most of the independent facilities being managed by chains.
  • The service providers and patients faced challenges since the onset of the COVID-19 pandemic, some of which are unique as compared to other health facilities and treatment groups. For instance, hemodialysis (HD) patients visit centers at least three times a week and during each session, the patients are exposed to all the patients concurrently receiving treatment in a particular session, and to healthcare personnel along with any additional exposure during their travel to and from the center.
  • Mergers & acquisitions and collaborations are being preferred by the key players, enabling them to have a competitive edge by adding value to their services. For Instance, in March 2022, Fresenius Medical Care announced a merger with InterWell Health and Cricket Health for facilitating better kidney disorder solutions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Dialysis
    • 1.2.3. Facility
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Dialysis Centers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Dialysis Centers Market: Modality Business Analysis

  • 4.1. Modality Market Share, 2024 & 2030
  • 4.2. Modality Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. In-center
    • 4.4.1. In-center Market, 2018 - 2030 (USD Million)
  • 4.5. In-home
    • 4.5.1. In-home Market, 2018 - 2030 (USD Million)
  • 4.6. SNF-based
    • 4.6.1. SNF-based Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Dialysis Centers Market: Dialysis Business Analysis

  • 5.1. Dialysis Market Share, 2024 & 2030
  • 5.2. Dialysis Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Dialysis, 2018 to 2030 (USD Million)
  • 5.4. Hemodialysis
    • 5.4.1. Hemodialysis Market, 2018 - 2030 (USD Million)
  • 5.5. Peritoneal Dialysis
    • 5.5.1. Peritoneal Dialysis Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Dialysis Centers Market: Facility Business Analysis

  • 6.1. Facility Market Share, 2024 & 2030
  • 6.2. Facility Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Facility, 2018 to 2030 (USD Million)
  • 6.4. Dialysis Chains
    • 6.4.1. Dialysis Chains Market, 2018 - 2030 (USD Million)
  • 6.5. Independent Facilities
    • 6.5.1. Independent Facilities Market, 2018 - 2030 (USD Million)
  • 6.6. Hospital-based
    • 6.6.1. Hospital-based Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Dialysis Centers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. West
    • 7.4.1. West U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Midwest
    • 7.5.1. Midwest U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Northeast
    • 7.6.1. Northeast U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Southeast
    • 7.7.1. Southeast U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Southwest
    • 7.8.1. Southwest U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Fresenius Medical Care AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. U.S. Renal Care, Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. DaVita Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Innovative Renal Care
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. DCI
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. SATELLITE HEALTHCARE
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Northwest Kidney Centers
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Centers for Dialysis Care
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Rogosin Institute
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Dialysis Care Center
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. USCF Health (The Regents of The University of California)
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Rhode Island Hospital, Department of Health Rhode Island
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. University of Iowa Hospital & Clinics
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives
    • 8.5.14. Saint Anthony Hospital
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial Performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic Initiatives
    • 8.5.15. Rush University Children's Hospital
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial Performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. dialysis centers market, by modality, 2018 - 2030 (USD Million)
  • Table 4 U.S. dialysis centers market, by dialysis, 2018 - 2030 (USD Million)
  • Table 5 U.S. dialysis centers market, by facility, 2018 - 2030 (USD Million)
  • Table 6 U.S. dialysis centers market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. dialysis centers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Modality and dialysis outlook (USD Million)
  • Fig. 10 Facility outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 U.S. dialysis centers market dynamics
  • Fig. 13 U.S. dialysis centers market: Porter's five forces analysis
  • Fig. 14 U.S. dialysis centers market: PESTLE analysis
  • Fig. 15 U.S. dialysis centers market: Modality segment dashboard
  • Fig. 16 U.S. dialysis centers market: Modality market share analysis, 2024 & 2030
  • Fig. 17 In-center market, 2018 - 2030 (USD Million)
  • Fig. 18 In-home market, 2018 - 2030 (USD Million)
  • Fig. 19 SNF-based market, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. dialysis centers market: Dialysis segment dashboard
  • Fig. 21 U.S. dialysis centers market: Dialysis market share analysis, 2024 & 2030
  • Fig. 22 Hemodialysis market, 2018 - 2030 (USD Million)
  • Fig. 23 Peritoneal dialysis market, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. dialysis centers market: Facility segment dashboard
  • Fig. 25 U.S. dialysis centers market: Facility market share analysis, 2024 & 2030
  • Fig. 26 Dialysis chains market, 2018 - 2030 (USD Million)
  • Fig. 27 Independent facilities market, 2018 - 2030 (USD Million)
  • Fig. 28 Hospital-based market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. dialysis centers market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 West U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 33 Midwest U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 34 Northeast U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 35 Southeast U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 36 Southwest U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 37 Company categorization
  • Fig. 38 Company market position analysis
  • Fig. 39 Strategic framework